Position in RLAY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$6,510,069
+$4,379,078 QoQ
Shares Held
347,946
+62.5% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#74
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. RLAY ranks #37 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,510,069 | 347,946 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,130,991 | 214,170 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,539,618 | 181,988 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $617,296 | 118,256 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $342,733 | 99,056 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $409,914 | 156,456 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $644,598 | 156,456 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,321,524 | 186,656 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,343,485 | 206,056 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,976,844 | 358,656 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,152,305 | 467,966 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,183,890 | 497,490 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $3,309,647 | 263,507 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,570,975 | 216,817 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,846,016 | 123,562 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,670,127 | 119,362 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,674,949 | 99,997 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,992,910 | 99,997 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,043,330 | 99,099 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $851,530 | 27,007 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $812,554 | 22,207 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $767,695 | 22,207 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $762,210 | 18,340 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $781,100 | 18,340 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||